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The neuroinflammatory neuropeptide substance P (SP) has been im-
plicated in oedema development following traumatic brain injury. Whether
the neuropeptide plays a role in concussive head injury is unknown.
Accordingly, we have used a newly developed model of mild head injury
in rats to characterise the release of SP following concussive brain injury.
Following brain trauma, there was no evidence of motor or cognitive
deficits over the ensuing 3 weeks. Despite this, increased SP immunore-
activity was present in perivascular axons, some pyramidal neurones and
astrocytes when compared to sham animals. Our findings suggest that
concussive brain injury predisposes an individual to diffuse brain swell-
ing, which may have implications in the management of sports related
concussion.
Introduction
Concussion is a mild form of traumatic brain injury (TBI) that by
definition incorporates immediate and transient impairment of neurologi-
cal function that may include alterations of consciousness, and distur-
bances of vision and/or equilibrium, amongst others (Committee of Head
Injury, 1966). In sporting events, mild head injury is common, and with-
out overt signs such as loss of consciousness, the concussion may go
untreated because few symptoms may be visible to the casual observer
(Maddocks et al, 1995). The danger in this is that a second concussive
event within a short period of time may lead to a condition that has been
termed ‘second impact syndrome’. While not universally accepted as a
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syndrome in itself (McCrory, 2001), it is widely recognized that young
athletes may exhibit diffuse cerebral swelling as a complication of diffuse
TBI, and that this may be exacerbated while symptomatic from an earlier
concussive event (Cantu, 1998; Saunders & Harbaugh, 1984).
The mechanisms associated with the development of diffuse cerebral
swelling following mild TBI still remains unclear. We have recently shown
in an experimental model of severe, diffuse TBI that neuropeptide release
leads to an opening of the blood brain barrier and profound oedema
formation (Nimmo et al., 2004). Moreover, the neuropeptide responsible
for the increased vascular permeability and subsequent oedema formation
was identified as substance P, and inhibition of its actions prevented
oedema formation and resulted in a highly significant improvement in
post-traumatic neurological outcome. However, it is not always possible
to extrapolate results from severe TBI to a condition of mild TBI, given
the absence of many of the neuropathological changes at the lower injury
severity. Accordingly, the aim of the present study was to identify whether
the neuroinflammatory neuropeptide, substance P, was released following
a mild (concussive) level of head injury.
Materials and Methods
All experimental protocols were approved and conducted according to
the guidelines established for the use of animals in experimental research
as outlined by the Australian National Health and Medical Research Council.
Adult male Sprague–Dawley rats (n=24; 400 ± 25 g) were subjected
to a mild TBI using the newly developed Cernak model of impact accel-
eration brain injury (Cernak et al., 2004). Briefly, animals were anaesthe-
tised with halothane, the skull exposed with a midline incision, and a
stainless steel disc (10 X 3 mm) fixed centrally on the exposed skull
between lambda and bregma using polyacrylamide adhesive. The animal
was then placed vertically beneath an accelerating metal impactor and
injury induced by initiating contact between the impactor and the metal
disc fixed to the animal’s skull. The distance the impactor travelled after
contacting the disc was restricted to less than 15 mm, equating to a mild
TBI. A further 15 animals were used as sham (surgery but no impact)
controls.
After injury, motor and cognitive outcome (n=6/group) was assessed
using the rotarod and Barnes Maze tests, respectively, as previously de-
scribed in detail elsewhere (Nimmo et al., 2004). Briefly, the rotarod test
requires an animal to walk on a motorised rotating assembly of 18 rods
for up to 2 min as the rotational speed of the assembly is increased from
0 to 30 revolutions per minute. The duration in seconds at which the
animal completes the task or falls from the rods is recorded. The Barnes
maze requires the animal to be placed under a cover in the centre of an
elevated 1.2-m diameter platform containing 19 holes around the periph-
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ery. One of the holes is the entrance to a darkened escape tunnel and is
not visible from the surface of the platform. After activating a series of
bright lights and an aversive sound, the cover is lifted and the latency in
seconds for the animal to locate and enter the darkened escape tunnel is
recorded.
For immunohistochemical analyses, injured and sham animals were
anaesthetised with halothane at 3 days or 5 days post-trauma (n = 3/time
point), and were perfused transcardially with 4% paraformaldehyde for 1
to 2 min. The brains were then removed and coronal sections (3–5 mm)
cut and embedded in paraffin. Serial sections (5 µm) were cut from
approximately – 4.0 mm relative to bregma using a Leitz rotary micro-
tome (Leica, Malvern, PA) and mounted on poly-L-lysine coated slides
for staining with haematoxylin and eosin (H&E), APP (monoclonal an-
tibody 22C11) or substance P.
Results
As expected at this mild level of TBI, no injured animal displayed any
motor or cognitive deficits as compared to sham animals (results not shown).
This was consistent with the absence of any axonal injury at any time
point as identified by APP immunostaining, and the lack of overt cell
death in H&E stained sections. Minor and transient dark cell change was
apparent in the hippocampus at 3 days post-trauma, but no significant
changes were observed in the cortex at any time point. These changes are
consistent with a concussive level of injury that may be accompanied by
a mild and transient cognitive deficit that remained undetected in our tests.
In contrast to the absence of any significant neuropathological or
neurological changes after injury, all injured animals demonstrated a profound
increase in substance P immunoreactivity (Fig. 1). This was particularly
Figure 1. Substance P immunoreactivity in shams (A) and at 3 days following
mild concussive traumatic brain injury (B) in rats. Note the darkly stained substance
P positive axons around the cortical vessels and the presence of substance P positive
neurones after injury (B). Bar = 100µm.
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apparent in the cortex within cortical perivascular axons, some pyramidal
neurones and in astrocytes. There were also substance P positive neu-
rones in the hippocampus.
Conclusions
Increased substance P immunoreactivity after mild TBI was apparent
in the absence of any overt functional deficits (motor or cognitive) or any
significant neuropathological changes. Because substance P is one of the
main neuropeptides involved in the development of neurogenic inflam-
mation (Campos and Calixto, 2000), our results suggest that even mild
TBI may lead to the development of diffuse cerebral swelling. It remains
to be determined if a second impact of an injured brain that is undergoing
substance P release exacerbates the resultant injury.
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